Status:
NOT_YET_RECRUITING
Remote Evaluation and Alerting for Collaborative Health (REACH) in Depression
Lead Sponsor:
Dartmouth-Hitchcock Medical Center
Collaborating Sponsors:
National Center for Advancing Translational Sciences (NCATS)
Conditions:
Depression
Major Depressive Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Researchers hope to see if the data smartphones collect continuously can be used to predict if patient's depression symptoms will return. They will do this by collecting data from patient's smartphone...
Detailed Description
Study phase 1: The investigators expect that participants will be in this research study for six months. Participants will be asked to download an app on their smartphone. This app will collect data f...
Eligibility Criteria
Inclusion
- Adult patients (18 years or older)
- Treated for depression within Dartmouth Health collaborative care model (CoCM) sites who are discharged from CoCM without depression (PHQ-9 \< 10)
- Have access to and ability to use a smartphone (Android version ≥ 6 or iOS version ≥ 11).
Exclusion
- Identified as high risk due to active suicidality, psychosis, or bipolar disorder - Discharged from CoCM with ongoing depressive symptoms (PhQ-9 \> 10
Key Trial Info
Start Date :
January 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2029
Estimated Enrollment :
320 Patients enrolled
Trial Details
Trial ID
NCT07174557
Start Date
January 1 2026
End Date
November 1 2029
Last Update
December 17 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Dartmouth College
Hanover, New Hampshire, United States, 03755
2
Dartmouth-Hitchcock Clinics
Lebanon, New Hampshire, United States, 03766